Skip to main content

Published locations for Recurrent HCC: Adjuvant sorafenib after RFA offers survival benefit over RFA alone

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Recurrent HCC: Adjuvant sorafenib after RFA offers survival benefit over RFA alone

User login

  • Reset your password
  • /content/recurrent-hcc-adjuvant-sorafenib-after-rfa-offers-survival-benefit-over-rfa-alone-0
  • /fedprac/article/257252/hepatocellular-carcinoma/recurrent-hcc-adjuvant-sorafenib-after-rfa-offers